Regarding: Apixaban, edoxaban and rivaroxaban, but not dabigatran, are associated with higher mortality compared to vitamin K antagonists

J Intern Med. 2025 Jan;297(1):117-118. doi: 10.1111/joim.20044. Epub 2024 Dec 9.
No abstract available

Publication types

  • Letter